期刊文献+

急性髓性白血病患者异基因造血干细胞移植后早期T细胞免疫重建的研究 被引量:1

下载PDF
导出
摘要 目的:监测急性髓性白血病(AML)患者接受异基因造血干细胞移植(allo-HSCT)后外周血中的T细胞受体重排删除环(TRECs)水平,了解移植后早期的T细胞免疫重建情况。方法:AML患者15例分别在allo-HSCT前以及allo-HSCT后每隔2周收集外周血,采用实时定量PCR法检测外周血单个核细胞(PBMNCs)中的TRECs水平;7例年龄相近的正常人外周血样本作为对照。流式检测CD45RA+细胞亚群和CD45RO+细胞亚群的阳性率。结果:allo-HSCT组移植前的TRECs平均拷贝数为(1.42±1.51)拷贝/1000 PBMNCs,明显低于正常组的(3.03±0.45)拷贝/1000 PBMNCs水平;移植后第12周的TRECs平均拷贝数为(1.67±1.93)拷贝/1000 PBMNCs,与正常相比仍然较低。移植后8周内以CD45RO+/CD4+细胞的扩增为主,而外周血TRECs水平在allo-HSCT后4周左右出现短暂地升高趋势,随后又下降,至allo-HSCT8周后才开始稳步上升。有急性移植物抗宿主病(aGVHD)病史的移植患者的外周血TRECs水平显著降低,明显低于无aGVHD病史移植患者的外周血TRECs水平。3例移植后早期复发的患者的外周血TRECs水平降至基线水平或检测不到。结论:不同个体T细胞免疫重建时间存在差异;AML患者在allo-HSCT后早期(90d内)的胸腺输出功能仍处于恢复阶段,移植后4周内的免疫重建仍以来源于供者细胞的外周扩增为主;外周血TRECs水平可能与AML患者allo-HSCT后病情的发展、转归有关。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第9期828-830,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30270579) 广东省自然科学基金重点项目(23001) 广东省教育厅"千百十工程"优秀人才培养基金项目(Q校02022) 中国博士后科学基金资助项目(20080440776)
  • 相关文献

参考文献8

  • 1Naylor K,Li G,Vallejo AN,et al.The influence of age on T cell generation and TCR diversity[J].J Immunol,2005,174(11):7446-7452.
  • 2李扬秋,韩素芳,杨力建,陈少华,周羽竝,陈嘉愉,刘薇薇.重度苯中毒患者胸腺输出近期功能明显低下[J].中国实验血液学杂志,2005,13(1):114-117. 被引量:18
  • 3Li B,Li YQ,Yang LJ,et al.Decreased T-cell receptor excision DNA circles in peripheral blood mononuclear cells among benzene-exposed workers[J].Int J Immunogenet,2009,36(2):107-111.
  • 4耿素霞,李扬秋,陈少华,杨力建,尹青松,吴秀丽,张学利.慢性粒细胞白血病患者外周血初始T细胞水平和T细胞受体Vβ谱系利用特点[J].中华血液学杂志,2005,26(7):413-416. 被引量:10
  • 5Mitchell WA,Meng I,Nicholson SA,et al.Thymic output,ageing and zinc[J].Biogerontology,2006,7(5-6):461-470.
  • 6Przybylski GK,Kreuzer KA,Siegert W,et al.No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD[J].J Appl Genet,2007,48(4):397-404.
  • 7Clave E,Rocha V,Talvensaari K,et al.Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation[J].Blood,2005,105(6):2608-2613.
  • 8尹青松,李扬秋,陈少华,杨力建,卢育洪,张学利.正常人外周血和脐血中TCRVβ亚家族sjTRECs的检测情况[J].细胞与分子免疫学杂志,2006,22(4):477-479. 被引量:5

二级参考文献31

  • 1李扬秋,杨力建,陈少华,周羽竝,耿素霞秋,陈青山.AML-M5患者外周血naiveT细胞水平和TCRVβ谱系利用特点[J].现代临床医学生物工程学杂志,2004,10(4):283-286. 被引量:6
  • 2尹青松,李扬秋,陈少华,杨力建,耿素霞.AML患者外周血中TCR Vβ2-、Vβ5-和Vβ17-Dβ1 sjTRECs的检测[J].暨南大学学报(自然科学与医学版),2005,26(4):475-479. 被引量:5
  • 3金伯泉.细胞和分子免疫学[M](第2版)[M].北京:科学出版社,2003.396-410.
  • 4Li Q, Kasten-Jolly J, Yen Y, et al. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase. Toxicol Appl Pharmacol, 1998;150:154 - 157
  • 5Farris GM, Robinson SN, Wong BA, et al. Effects of benzene on splenic, thymic, and femoral lymphocytes in mice. Toxicology,1997; 118:137- 148
  • 6Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature, 1998; 396:690 - 695
  • 7Stillman WS, Varella-Garcia M, Irons RD. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34 + CD19 + bone marrow cells. Exp Hematol, 2000; 28:169176
  • 8Rothman N, Smith MT, Hayes RB, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res, 1997; 57:2839-2842
  • 9Kimmig S, Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral. J Exp Med, 2002; 195:789-794
  • 10Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood, 2001; 98:1116 - 1121

共引文献27

同被引文献16

  • 1刘启发,范志平,孙竞,易正山,徐丹,张钰,魏永强,叶昌雄,杨凯,孟凡义.两种方案预防无血缘关系供者造血干细胞移植后移植物抗宿主病的效果比较[J].中华血液学杂志,2006,27(8):550-552. 被引量:4
  • 2Laport GG, Alvarnas JC, Palmer JM, et al. Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiationetoposide regimen.Blood,2008,112(3):903-909.
  • 3Socié G, Clift RA, Blaise D, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia:long-term follow up of 4 randomized studies.Blood,2001,98(13):3569-3574.
  • 4Stelljes M,Bornhauser M,Kroger M,et al. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.Blood,2005,106(9):3314-3321.
  • 5Davies SM,Ramsay NK,Klein JP,et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.J Clin Oncol,2000,18(2):340-347.
  • 6Blaise D,Maraninchi D,Michallet M,et al. Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan asconditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.Blood,2001,97(11):3669-3671.
  • 7Ferry C,Soci G.Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Exp Hematol,2003,31(12):1182-1186.
  • 8Shi Xia X,Xian-Hua T, Hai-Qin X, et al. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation:a meta-analysis.Leuk Lymphoma,2010,51 (1):50-60.
  • 9Uberti JP,Agovi MA,Tarima S,et al.Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.Bone Marrow Transplant,2011,46 (1):34-43.
  • 10Litzow MR,P rez WS, Klein JP, et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission.Br J Haematol,2002,119(4):1115-1124.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部